Pfizer’s Paxlovid Antiviral to Undergo Trial as Long Covid Medicament

Name: Pfizer’s Paxlovid Antiviral to Undergo Trial as Long Covid Medicament
Uploaded: 2022-10-28T13:17:15+00:00
Duration: P65S
Description: A trial is set to begin on January 1st to investigate a prime cause and cure for long Covid. Veuer’s Chloe Hurst has the story!

Credit: Veuer

Duration: 01:05s 28 Oct 2022 0 shares 4 views

Pfizer’s Paxlovid Antiviral to Undergo Trial as Long Covid Medicament

A trial is set to begin on January 1st to investigate a prime cause and cure for long Covid.

Veuer’s Chloe Hurst has the story!

Pfizer’s Paxlovid Antiviral to Undergo Trial as Long Covid Medicament

You might like